Paeds SAQs · fetal-neonatal-and-perinatal
Parenteral nutrition in neonates — formative SAQs
Formative SAQs.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DCEMRCPCH Clinical
Prompt
Parenteral nutrition in neonates
SAQ 1 (10)
A 780 g infant is born at 26 weeks' gestation. A umbilical venous catheter is sited at one hour of life and the team asks you to prescribe the parenteral nutrition for the first day. [2] [6]
- Explain why the very preterm infant needs early aggressive parenteral nutrition. (3) [2]
- State the day-one starting doses and the ESPGHAN advancement targets for amino acids, glucose (as a glucose infusion rate) and lipid. (4) [6]
- Outline the daily monitoring schedule and the four complications you actively prevent. (3) [4]
Model answer
- Most glycogen, fat and protein stores are deposited in the third trimester the infant never completed, so the very preterm carries the smallest reserve at the moment of highest metabolic demand; the fetal protein accretion rate is 3.5 to 4 g/kg/day, the most anabolic period of life. Withholding nutrition flips this anabolic state into negative nitrogen balance within hours, with loss of brain and somatic growth that does not fully recover, so early amino acids directly after birth are a developmental necessity. [2]
- Day one starts amino acids at 1.5 to 2 g/kg/day, a glucose infusion rate of 4 to 6 mg/kg/min, and lipid at 1 to 2 g/kg/day. Advance over the first days to the ESPGHAN targets of amino acids 3 to 3.5 g/kg/day, glucose infusion rate 10 to 12 mg/kg/min, and lipid 3 to 3.5 g/kg/day, with energy around 110 to 135 kcal/kg/day. [6]
- Daily monitoring covers glucose each shift, daily weight on a gestation-specific chart, the electrolyte and metabolic panel (sodium, potassium, chloride, bicarbonate, calcium, phosphate, magnesium), triglycerides when advancing lipid, and liver function from the second week. The four complications to prevent are catheter-related bloodstream infection, PN-associated cholestasis (IFALD), metabolic derangement (hyperglycaemia and lipid intolerance), and refeeding syndrome. [4]
References6ShowHide
- [1]Koletzko B Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). Journal of Pediatric Gastroenterology and Nutrition, 2005.PMID 16254497
- [2]te Braake FW Amino acid administration to premature infants directly after birth. Journal of Pediatrics, 2005.PMID 16227030
- [3]Fivez T Early versus Late Parenteral Nutrition in Critically Ill Children. New England Journal of Medicine, 2016.PMID 26975590
- [4]Hojsak I ESPGHAN position paper: intravenous lipid emulsions and risk of hepatotoxicity. Journal of Pediatric Gastroenterology and Nutrition, 2016.PMID 26825766
- [5]Puder M Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Annals of Surgery, 2009.PMID 19661785
- [6]van Goudoever JB ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids. Clinical Nutrition, 2018.PMID 30100107